Trefor Owen Morgan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Trefor Owen Morgan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Adrianne Anderson
Hypertension Clinic, ARMC, Heidelberg, Victoria, 3084, Australia
2 shared publicationsDenise Bertram
Hypertension Clinic, ARMC, Heidelberg, Victoria, 3084, Australia
2 shared publicationsAnne Pigeon
Repatriation General Hospital
1 shared publicationG. Rennie
OR Systems
1 shared publicationJ. Joughin
Bristol-Myers Squibb
1 shared publicationOlive Morgan
Repatriation General Hospital
1 shared publication
Latest Publications
- 1 February 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (2) , 263-265
Should blood pressure medication be taken in the morning or evening?
- 1 February 2015
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 33 (2) , 263-265
Should blood pressure medication be taken in the morning or evening?
- 1 June 2010
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 8 (6) , 803-809
The importance of sleep blood pressure
Blood pressure (BP) varies throughout the day owing to interactions between the sympathetic nervous and the renin-angiotensin systems. When awake BP is controlled by sympathetic nervous system activity but during sleep the renin-angiotensin system becomes more important. The lower BP during sleep is a more powerful predictor of outcome than the awake BP. Certain individuals do not have the fall in BP with sleep and this worsens the outcome. Inadequate handling of sodium by the kidney is an important factor preventing this BP fall. The different drug classes have varying effects on BP during 24 h. Drugs that act independently of the two controlling systems have a similar effect at day and night. Drugs that act on the sympathetic nervous system have a greater effect during the day and little effect during sleep unless the sympathetic system is still active. Drugs that act via the renin-angiotensin system have a greater effect during sleep. Controlling BP during sleep may improve outcome.
- 1 June 2010
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 8 (6) , 803-809
The importance of sleep blood pressure
Blood pressure (BP) varies throughout the day owing to interactions between the sympathetic nervous and the renin-angiotensin systems. When awake BP is controlled by sympathetic nervous system activity but during sleep the renin-angiotensin system becomes more important. The lower BP during sleep is a more powerful predictor of outcome than the awake BP. Certain individuals do not have the fall in BP with sleep and this worsens the outcome. Inadequate handling of sodium by the kidney is an important factor preventing this BP fall. The different drug classes have varying effects on BP during 24 h. Drugs that act independently of the two controlling systems have a similar effect at day and night. Drugs that act on the sympathetic nervous system have a greater effect during the day and little effect during sleep unless the sympathetic system is still active. Drugs that act via the renin-angiotensin system have a greater effect during sleep. Controlling BP during sleep may improve outcome.
- 27 February 2008
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 35 (4) , 470-472
IMPORTANCE OF SLEEP BLOOD PRESSURE
- 27 February 2008
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 35 (4) , 470-472
IMPORTANCE OF SLEEP BLOOD PRESSURE
- Open Access
- 1 June 2004
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 5 (2) , 64-71
Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria
Background Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blocking drugs (ARB) block the effect of angiotensin II by different mechanisms. It has been suggested that combined therapy may be more effective at reducing blood pressure (BP) than higher doses of either drug. Methods Twenty-three elderly patients with systolic hypertension completed a double-blind crossover study comparing placebo, candesartan (C) 16 mg, C32 mg, lisinopril (L) 20 mg, L40 mg and C16 mg + L20 mg. Treatment periods were one month and ambulatory BP measurements were performed at the end of each period. The effects on albumin excretion in eight patients with microalbuminuria were determined. Results All treatments lowered BP. The falls in systolic and diastolic BP with C16, C32, L20 and L40 were similar. Plasma renin rose to a similar extent. A plateau effect was reached with C16 and L20. Systolic BP on the combination of C16 + L20 was lower than on each monotherapy (C16, 3.8 mmHg [p=0.002]; C32, 6.4 [0.0003]; L20, 2.9 [0.05]; L40, 3.3 [0.003]). The additional fall in BP with the combination appeared to be due to recruitment of non-responders, rather than to an additive effect in most patients. All treatments reduced microalbuminuria to a similar extent. The combination was well tolerated and there was no deterioration in renal function. Conclusion When patients are on a plateau dose of an ACE inhibitor or an ARB, addition of the other drug class has a small but significant incremental effect on BP in the overall group. However, some patients respond better to one drug class than to the other and this may explain the results. This study lends no support to the use of these two drugs in combination to treat hypertension.
- 1 June 2004
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 5 (2) , 64-71
Open AccessEffect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria
Background Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blocking drugs (ARB) block the effect of angiotensin II by different mechanisms. It has been suggested that combined therapy may be more effective at reducing blood pressure (BP) than higher doses of either drug. Methods Twenty-three elderly patients with systolic hypertension completed a double-blind crossover study comparing placebo, candesartan (C) 16 mg, C32 mg, lisinopril (L) 20 mg, L40 mg and C16 mg + L20 mg. Treatment periods were one month and ambulatory BP measurements were performed at the end of each period. The effects on albumin excretion in eight patients with microalbuminuria were determined. Results All treatments lowered BP. The falls in systolic and diastolic BP with C16, C32, L20 and L40 were similar. Plasma renin rose to a similar extent. A plateau effect was reached with C16 and L20. Systolic BP on the combination of C16 + L20 was lower than on each monotherapy (C16, 3.8 mmHg [p=0.002]; C32, 6.4 [0.0003]; L20, 2.9 [0.05]; L40, 3.3 [0.003]). The additional fall in BP with the combination appeared to be due to recruitment of non-responders, rather than to an additive effect in most patients. All treatments reduced microalbuminuria to a similar extent. The combination was well tolerated and there was no deterioration in renal function. Conclusion When patients are on a plateau dose of an ACE inhibitor or an ARB, addition of the other drug class has a small but significant incremental effect on BP in the overall group. However, some patients respond better to one drug class than to the other and this may explain the results. This study lends no support to the use of these two drugs in combination to treat hypertension.
- 1 June 1995
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 9 (6) , 314-323
Effect of Pravastatin, Cholestyramine or their Combination in the Treatment of Hypercholesterolaemia in Elderly Hypertensive Patients
- 1 June 1995
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 9 (6) , 314-323
Effect of Pravastatin, Cholestyramine or their Combination in the Treatment of Hypercholesterolaemia in Elderly Hypertensive Patients